Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 18,937 followers.

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessm… https://t.co/D7dIEC3Kp4

27 Oct 2023

Reply Repost Favourite

RT @FrontOncology: New research: Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarke…

07 Sep 2023

Reply Repost Favourite

New research: Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment: Introduction Iloprost, a prostacyclin analog, has lung cancerpreventive activity in preclinical models and… #oncology htt

06 Sep 2023

Reply Repost Favourite

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment https://t.co/RnumvTqLsI

05 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.